191 related articles for article (PubMed ID: 19726405)
21. Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2.
Ruiz-Martínez J; de la Riva P; Rodríguez-Oroz MC; Mondragón Rezola E; Bergareche A; Gorostidi A; Gago B; Estanga A; Larrañaga N; Sarasqueta C; López de Munain A; Martí Massó JF
Mov Disord; 2014 May; 29(6):750-5. PubMed ID: 24357540
[TBL] [Abstract][Full Text] [Related]
22. Risk of cancer among Finnish multiple sclerosis patients.
Hongell K; Kurki S; Sumelahti ML; Soilu-Hänninen M
Mult Scler Relat Disord; 2019 Oct; 35():221-227. PubMed ID: 31404761
[TBL] [Abstract][Full Text] [Related]
23. Prospective case-control study of nonfatal cancer preceding the diagnosis of Parkinson's disease.
Driver JA; Kurth T; Buring JE; Gaziano JM; Logroscino G
Cancer Causes Control; 2007 Sep; 18(7):705-11. PubMed ID: 17562193
[TBL] [Abstract][Full Text] [Related]
24. Cancer incidence among Parkinson's disease patients in a 10-yrs time-window around disease onset: A large-scale cohort study.
Peretz C; Gurel R; Rozani V; Gurevich T; El-Ad B; Tsamir J; Giladi N
Parkinsonism Relat Disord; 2016 Jul; 28():68-72. PubMed ID: 27161827
[TBL] [Abstract][Full Text] [Related]
25. Nationwide incidence of motor neuron disease using the French health insurance information system database.
Kab S; Moisan F; Preux PM; Marin B; Elbaz A
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Aug; 18(5-6):426-433. PubMed ID: 28387141
[TBL] [Abstract][Full Text] [Related]
26. Motor neuron disease and multiple sclerosis mortality in Australia, New Zealand and South Africa compared with England and Wales.
Dean G; Elian M
J Neurol Neurosurg Psychiatry; 1993 Jun; 56(6):633-7. PubMed ID: 8509776
[TBL] [Abstract][Full Text] [Related]
27. A review of xenobiotic metabolism enzymes in Parkinson's disease and motor neuron disease.
Steventon GB; Sturman S; Waring RH; Williams AC
Drug Metabol Drug Interact; 2001; 18(2):79-98. PubMed ID: 11460878
[TBL] [Abstract][Full Text] [Related]
28. TIGAR inclusion pathology is specific for Lewy body diseases.
López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
[TBL] [Abstract][Full Text] [Related]
29. Epidemiological characteristics of motor neuron disease in Chinese patients.
Cui F; Liu M; Chen Y; Huang X; Cui L; Fan D; Pu C; Lu J; Zhou D; Zhang C; Yan C; Li C; Ding X; Liu Y; Li X; Jiang Y; Zhang J; Shang H; Yao X; Ding Y; Niu Q; Wang L
Acta Neurol Scand; 2014 Aug; 130(2):111-7. PubMed ID: 24689740
[TBL] [Abstract][Full Text] [Related]
30. The changing mortality from motor neurone disease and multiple sclerosis in England and Wales and the Republic of Ireland.
Elian M; Dean G
Neuroepidemiology; 1992; 11(4-6):236-43. PubMed ID: 1291887
[TBL] [Abstract][Full Text] [Related]
31. Comorbid cancer in Parkinson's disease.
Lo RY; Tanner CM; Van Den Eeden SK; Albers KB; Leimpeter AD; Nelson LM
Mov Disord; 2010 Sep; 25(12):1809-17. PubMed ID: 20669266
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study.
Turner MR; Wotton C; Talbot K; Goldacre MJ
J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):395-8. PubMed ID: 22072701
[TBL] [Abstract][Full Text] [Related]
33. TDP43-positive intraneuronal inclusions in a patient with motor neuron disease and Parkinson's disease.
Chanson JB; Echaniz-Laguna A; Vogel T; Mohr M; Benoilid A; Kaltenbach G; Kiesmann M
Neurodegener Dis; 2010; 7(4):260-4. PubMed ID: 20197650
[TBL] [Abstract][Full Text] [Related]
34. Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease.
Chancellor AM; Swingler RJ; Fraser H; Clarke JA; Warlow CP
J Epidemiol Community Health; 1993 Apr; 47(2):116-20. PubMed ID: 8326268
[TBL] [Abstract][Full Text] [Related]
35. Motor neuron disease mortality rates in New Zealand 1992-2013.
Cao MC; Chancellor A; Charleston A; Dragunow M; Scotter EL
Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):285-293. PubMed ID: 29382218
[TBL] [Abstract][Full Text] [Related]
36. Ubiquitin-only intraneuronal inclusion in the substantia nigra is a characteristic feature of motor neurone disease with dementia.
Al-Sarraj S; Maekawa S; Kibble M; Everall I; Leigh N
Neuropathol Appl Neurobiol; 2002 Apr; 28(2):120-8. PubMed ID: 11972798
[TBL] [Abstract][Full Text] [Related]
37. Accuracy of death certificates for motor neuron disease and multiple sclerosis in the province of Palermo in southern Italy.
Ragonese P; Salemi G; Aridon P; Conte S; Cuccia G; Lupo I; Savettieri G
Neuroepidemiology; 2002; 21(3):148-52. PubMed ID: 12006778
[TBL] [Abstract][Full Text] [Related]
38. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
Conde B; Winck JC; Azevedo LF
Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
[TBL] [Abstract][Full Text] [Related]
39. A Systematic Review of Case-Identification Algorithms Based on Italian Healthcare Administrative Databases for Three Relevant Diseases of the Nervous System: Parkinson's Disease, Multiple Sclerosis, and Epilepsy.
Canova C; Danieli S; Barbiellini Amidei C; Simonato L; Di Domenicantonio R; Cappai G; Bargagli AM
Epidemiol Prev; 2019; 43(4 Suppl 2):62-74. PubMed ID: 31650807
[TBL] [Abstract][Full Text] [Related]
40. Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson's disease, mild cognitive impairment, Alzheimer's disease, and elderly healthy controls.
Jakimovski D; Bergsland N; Dwyer MG; Hagemeier J; Ramasamy DP; Szigeti K; Guttuso T; Lichter D; Hojnacki D; Weinstock-Guttman B; Benedict RHB; Zivadinov R
Neurobiol Aging; 2020 Jun; 90():84-92. PubMed ID: 32147244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
